BLFS
NASDAQ
$29.09
Biolife Solutions Inc (BLFS)
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Buy
Target: $32.11 (+10.38%)
Market Cap
$1.42B
Free Cash Flow Yield
0.58%
Beta (5Y)
1.34
Price Chart
Valuation
Market Cap$1.42B
Forward P/E263.16
PEG65.38
P/S13.77
P/B3.68
Profitability
Total Revenue (TTM)$102M
Gross Profit (TTM)$65M
EBITDA-$14M
Profit Margin4.3%
Operating Margin0.1%
EPS-$0.06
Financial Health
Debt-to-Equity1.3%
Free Cash Flow Yield0.58%
Growth & Risk
EPS 5Y CAGR-39.39%
Revenue 5Y CAGR+14.01%
FCF 5Y CAGR+14.23%
Beta (5Y)1.34
Sharpe Ratio0.82